Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1875 1
1876 3
1877 3
1878 15
1879 1
1880 1
1881 1
1888 1
1889 2
1890 1
1891 1
1933 1
1934 1
1962 1
1975 1
1976 1
1977 1
1978 1
1979 2
1980 1
1981 2
1982 5
1983 1
1984 1
1985 2
1986 2
1987 3
1988 3
1989 3
1990 4
1992 5
1993 2
1994 5
1995 1
1996 5
1997 4
1999 3
2000 3
2001 11
2002 5
2003 8
2004 4
2005 5
2006 4
2007 5
2008 7
2009 8
2010 7
2011 10
2012 10
2013 4
2014 2
2015 5
2016 8
2017 3
2018 4
2019 1
2020 7
2021 5
Text availability
Article attribute
Article type
Publication date

Search Results

199 results
Results by year
Filters applied: . Clear all
Page 1
Evaluation of Combination Nivolumab and Ipilimumab Immunotherapy in Patients With Advanced Biliary Tract Cancers: Subgroup Analysis of a Phase 2 Nonrandomized Clinical Trial.
Klein O, Kee D, Nagrial A, Markman B, Underhill C, Michael M, Jackett L, Lum C, Behren A, Palmer J, Tebbutt NC, Carlino MS, Cebon J. Klein O, et al. Among authors: underhill c. JAMA Oncol. 2020 Sep 1;6(9):1405-1409. doi: 10.1001/jamaoncol.2020.2814. JAMA Oncol. 2020. PMID: 32729929 Clinical Trial.
Immunotherapy of Ipilimumab and Nivolumab in Patients with Advanced Neuroendocrine Tumors: A Subgroup Analysis of the CA209-538 Clinical Trial for Rare Cancers.
Klein O, Kee D, Markman B, Michael M, Underhill C, Carlino MS, Jackett L, Lum C, Scott C, Nagrial A, Behren A, So JY, Palmer J, Cebon J. Klein O, et al. Among authors: underhill c. Clin Cancer Res. 2020 Sep 1;26(17):4454-4459. doi: 10.1158/1078-0432.CCR-20-0621. Epub 2020 Jun 12. Clin Cancer Res. 2020. PMID: 32532787
Practical Considerations for Treating Patients With Cancer in the COVID-19 Pandemic.
Segelov E, Underhill C, Prenen H, Karapetis C, Jackson C, Nott L, Clay T, Pavlakis N, Sabesan S, Heywood E, Steer C, Lethborg C, Gan HK, Yip D, Karanth N, Karikios D, MacIntyre CR. Segelov E, et al. Among authors: underhill c. JCO Oncol Pract. 2020 Aug;16(8):467-482. doi: 10.1200/OP.20.00229. Epub 2020 May 13. JCO Oncol Pract. 2020. PMID: 32401686
CD44: the hyaluronan receptor.
Underhill C. Underhill C. J Cell Sci. 1992 Oct;103 ( Pt 2):293-8. J Cell Sci. 1992. PMID: 1282514 Review. No abstract available.
Outpatient rituximab, ifosfamide, etoposide (R-IE) in patients older than 60 years with relapsed or refractory diffuse large B-cell lymphoma who are not candidates for stem cell transplantation.
Joshi M, Taper J, Forsyth C, Rowlings P, Campbell P, Crispin P, Harvey M, Underhill C, Bayley A, Byth K, Huang G, Hertzberg M. Joshi M, et al. Among authors: underhill c. Leuk Lymphoma. 2020 Jan;61(1):91-97. doi: 10.1080/10428194.2019.1660968. Epub 2019 Sep 12. Leuk Lymphoma. 2020. PMID: 31512531
199 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page